Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by David McManus and Nathaniel Hafer.
Connection Strength

2.985
  1. Hafer N, Buchholz B, Dunlap D, Fournier B, Latham S, Picard MA, Tello S, Gibson L, Lilly CM, McManus DD. A multi-institutional partnership catalyzing the commercialization of medical devices and biotechnology products. J Clin Transl Sci. 2021; 5(1):e119.
    View in: PubMed
    Score: 0.902
  2. Dunlap DR, Santos RS, Lilly CM, Teebagy S, Hafer NS, Buchholz BO, McManus DD. COVID-19: a gray swan's impact on the adoption of novel medical technologies. Humanit Soc Sci Commun. 2022; 9(1):232.
    View in: PubMed
    Score: 0.246
  3. Soni A, Herbert C, Baek J, Shi Q, Marquez J, Harman E, Kheterpal V, Nowak C, Suvarna T, Lin H, Heetderks W, Zai A, Cohen-Wolkowiez M, Corbie-Smith G, Kibbe W, Gerber BS, Hafer N, Barton B, Broach J, McManus D. Association of Mass Distribution of Rapid Antigen Tests and SARS-CoV-2 Prevalence: Results from NIH-CDC funded Say Yes! Covid Test program in Michigan. medRxiv. 2022 Apr 02.
    View in: PubMed
    Score: 0.241
  4. Soni A, Herbert C, Filippaios A, Broach J, Colubri A, Fahey N, Woods K, Nanavati J, Wright C, Orwig T, Gilliam K, Kheterpal V, Suvarna T, Nowak C, Schrader S, Lin H, O'Connor L, Pretz C, Ayturk D, Orvek E, Flahive J, Lazar P, Shi Q, Achenbach C, Murphy R, Robinson M, Gibson L, Stamegna P, Hafer N, Luzuriaga K, Barton B, Heetderks W, Manabe YC, McManus D. Comparison of Rapid Antigen Tests' Performance between Delta (B.1.61.7; AY.X) and Omicron (B.1.1.529; BA1) Variants of SARS-CoV-2: Secondary Analysis from a Serial Home Self-Testing Study. medRxiv. 2022 Mar 02.
    View in: PubMed
    Score: 0.240
  5. Teebagy S, Wang Z, Dunlap D, Saleeba C, DiMezza D, Crain J, Lilly CM, Buchholz B, McManus DD, Hafer N. Understanding Healthcare Professionals' Perspectives on Point-of-Care Testing. Diagnostics (Basel). 2022 Feb 19; 12(2).
    View in: PubMed
    Score: 0.240
  6. Dunlap D, Ding E, Abramo K, Wang Z, Lilly CM, Hafer N, Buchholz B, McManus DD. Point-of-care testing, your cardiologist, and affairs of the heart. Cardiovasc Digit Health J. 2021 Dec; 2(6):331-335.
    View in: PubMed
    Score: 0.234
  7. Gibson L, Fahey N, Hafer N, Buchholz B, Dunlap D, Murphy R, Achenbach C, Stone C, Cleeton R, O'Neal J, Frediani J, Vos M, Brand O, Nayee R, Wells L, Lam W, Martin G, Manabe Y, Robinson M, Broach J, Olgin J, Barton B, Lemon S, Blodgett A, McManus D. The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies. IEEE Open J Eng Med Biol. 2021; 2:152-157.
    View in: PubMed
    Score: 0.226
  8. Lilly CM, Ensom E, Teebagy S, DiMezza D, Dunlap D, Hafer N, Buchholz B, McManus D. Patient Preferences for Point-of-Care Testing: Survey Validation and Results. Point Care. 2020 Dec; 19(4):112-115.
    View in: PubMed
    Score: 0.220
  9. Ding EY, Ensom E, Hafer N, Buchholz B, Picard MA, Dunlap D, Rogers E, Lawton C, Koren A, Lilly C, Fitzgibbons TP, McManus DD. Point-of-care technologies in heart, lung, blood and sleep disorders from the Center for Advancing Point-of-Care Technologies. Curr Opin Biomed Eng. 2019 Sep; 11:58-67.
    View in: PubMed
    Score: 0.203
  10. Herbert C, Kheterpal V, Suvarna T, Broach J, Marquez JL, Gerber B, Schrader S, Nowak C, Harman E, Heetderks W, Fahey N, Orvek E, Lazar P, Ferranto J, Noorishirazi K, Valpady S, Shi Q, Lin H, Marvel K, Gibson L, Barton B, Lemon S, Hafer N, McManus D, Soni A. Design and Preliminary Findings of Adherence to the Self-Testing for Our Protection From COVID-19 (STOP COVID-19) Risk-Based Testing Protocol: Prospective Digital Study. JMIR Form Res. 2022 Jun 16; 6(6):e38113.
    View in: PubMed
    Score: 0.061
  11. Herbert C, Shi Q, Kheterpal V, Nowak C, Suvarna T, Durnam B, Schrader S, Behar S, Naeem S, Tarrant S, Kalibala B, Singh A, Gerber B, Barton B, Lin H, Cohen-Wolkowiez M, Corbie-Smith G, Kibbe W, Marquez J, Baek J, Hafer N, Gibson L, O'Connor L, Broach J, Heetderks W, McManus D, Soni A. If you build it, will they use it? Use of a Digital Assistant for Self-Reporting of COVID-19 Rapid Antigen Test Results during Large Nationwide Community Testing Initiative. medRxiv. 2022 Apr 01.
    View in: PubMed
    Score: 0.060
  12. Nehl E, Heilman S, Ku D, Gottfried D, Farmer S, Mannino R, Tyburski E, Sullivan J, Suessmith A, Bassit L, Figueroa J, Wood A, Leong T, Rao A, Rogers B, Jerris R, Park S, Gonzalez M, Frediani J, Morris C, Levy J, Schoof N, Mavigner M, Roback J, Herzegh K, Saakadze N, Ingersoll J, Cheedarla N, Neish A, Hanberry B, Porter C, Esper A, Kempker R, Rebolledo P, McGuinness P, Balagadde F, Gore R, Koren A, Pollock N, Rogers E, Simin K, Hafer N, Picard MA, Ghezzi C, McManus D, Buchholz B, Rostad C, Claveria V, Ramachandra T, Wang YF, Washington C, Stone C, Griffiths M, Schinazi R, Chahroudi A, Vos M, Brand O, Martin G, Lam W. The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change. IEEE Open J Eng Med Biol. 2021 Apr 28; 2:142-151.
    View in: PubMed
    Score: 0.057
  13. Dunlap D, Santos RS, McManus DD, Buchholz BO, Hafer NS, Picard M. New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown. AIB Insights. 2020 Nov 03; 20(3).
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.